The 12 closest competitors and alternatives to Zumutor Biologics among biologics companies — ranked by similarity to what Zumutor Biologics actually does, not by market-cap band.
Subscribe to see Zumutor Biologics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Zumutor Biologics is an immuno-oncology company incorporated in the USA, with its primary office in Cambridge, Massachusetts. The company is a leading firm in the space of targeted NK cell therapeutics and utilizes proprietary naïve human phage/yeast display technology.
Zumutor Biologics is a biologics company headquartered in United States. It has raised at least $13.5M across the 2 funding rounds on record. Its most recent funding round, Series B, raised $7.3M in June 2026. Xcout tracks 2 named people at Zumutor Biologics, including Maloy Ghosh (chief scientific officer).
At least $13.5M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $7.3M | — | |
| — | $6.2M | 5 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to Zumutor Biologics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biopharmaceutical
Aviceda Therapeutics is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts, focused on glyco-immune checkpoint therapeutics. The company develops novel, immune-mediated therapies designed to treat inflammatory and blinding diseases. Their proprietary technology platform leverages glycobiology to modulate the immune system for patient benefit.
Drug Discovery
OncoMyx Therapeutics, Inc. is a biotechnology company headquartered in Phoenix, Arizona, that develops innovative oncolytic immunotherapies to target and destroy tumors.
Drug Discovery
Diagonal Therapeutics is a biotechnology company headquartered in Watertown, Massachusetts, pioneering disease-modifying clustering antibody therapeutics to target the root causes of devastating diseases.
Biopharmaceuticals
Lifordi Immunotherapeutics, Inc. is a clinical-stage biotechnology company based in Burlington, Massachusetts, focused on developing antibody-drug conjugates (ADCs).
Drug Discovery
Caldera Therapeutics, Inc. is a Cambridge, Massachusetts-based clinical-stage biotechnology company focused on treatments such as a bispecific inflammatory bowel disease (IBD) asset.
Biotherapeutics
Headquartered in South San Francisco, California, Chimera Bioengineering is a privately held biotechnology company focused on developing advanced cellular engineering technologies for cancer therapies.
Biopharmaceuticals
ARMO BioSciences is a late-stage immuno-oncology company that develops a pipeline of novel, proprietary product candidates designed to activate the immune system of cancer patients to recognize and eradicate tumors.
Biopharmaceuticals
Amunix Pharmaceuticals, Inc. is a biopharmaceutical company located in South San Francisco and Mountain View, California. The company focuses on oncology, leveraging its proprietary Pro-XTEN technology platform to engineer novel protein therapeutics.
Deep-Tech
East Ocyon Bio Private Limited is a leading cell and gene therapy company headquartered in India that is advancing cellular immunotherapy and developing treatments such as CAR-NK, CRISPR, and Gamma Delta T-cell therapies for cancer.
Drug Discovery
Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company headquartered in South San Francisco, California. It specializes in developing novel T-cell engaging therapies for the treatment of cancer.
Drug Discovery
Pieris Pharmaceuticals, Inc. is a clinical-stage biotechnology company headquartered in Boston, Massachusetts. The company discovers and develops Anticalin-based drugs designed to address significant medical needs.
Bio Tools
Drosera Bio is a privately held biotechnology company based in Cambridge, Massachusetts, that develops automation-native tools and material solutions to improve the efficiency and cost-effectiveness of bioprocesses.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Zumutor Biologicsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →